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Objectives: Interactions between mechanical and non-mechanical independent risk factors for the onset
and progression of Osteoarthritis (OA) are poorly understood. Therefore, the goal of the present study
was to investigate the in vivo effects of muscle weakness, joint inﬂammation and the combination on the
onset and progression of OA in a rabbit knee joint model.
Materials and methods: Thirty 1-year-old female New Zealand White rabbits (average 5.7 kg, range
4.8e6.6 kg) were divided into four groups with one limb randomly assigned to be the experimental
side: (1) surgical denervation of the vastus lateralis (VL) muscle; (2) muscle weakness induced by
intramuscular injection of Botulinum toxin A (BTX-A); (3) intraarticular injection with Carrageenan
to induce a transient inﬂammatory reaction; (4) combination of Carrageenan and BTX-A injection.
After 90 days, cartilage histology of the articular surfaces were microscopically analyzed using the
Osteoarthritis Research Society International (OARSI) histology scoring system.
Results: VL denervation resulted in signiﬁcantly higher OARSI scores in the patellofemoral joint (group
1). BTX-A administration resulted in signiﬁcant cartilage damage in all four compartments of the knee
(group 2). Carrageenan did not cause signiﬁcant cartilage damage. BTX-A combined with Carrageenan
lead to severe cartilage damage in all four compartments.
Conclusion: Muscle weakness lead to signiﬁcant OA in the rabbit knee. A transient local inﬂammatory
stimulus did not promote cartilage degradation nor did it enhance OA progression when combined with
muscle weakness. These results are surprising and add to the literature the conclusion that acute
inﬂammation is probably not an independent risk factor for OA in this rabbit model.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Estimated costs attributable to arthritis and other rheumatic
conditions (AORC) in the United states in 2003 were approximately
$128 billion1. The Arthritis Research Center of Canada calculated the
total cost of treating OA in Canada to be 1.8 billion dollars in 2010
and it is expected to quadruple over the next two decades to reach
$8.1 billion by the year 20312. Despite this substantial socio-
economic impact, the onset, natural history, or progression of OA





ternational. Published by Elsevier Lhas increasingly described OA as a whole joint disease and the
result of a complex interplay between several causes or risk factors.
Risk factors initiating or advancing OA can be grouped into
mechanical and non-mechanical factors. Mechanical alterations,
such as anterior cruciate ligament ruptures, meniscal tears, muscle
weakness and malalignment, especially in joints of the lower limb,
have been widely studied in animal models in vitro, and in human
studies3e8. Muscle weakness and atrophy is one of the earliest signs
and always accompanies OA9. Muscle weakness has also been
shown to be an independent risk factor for OA10 leading to
increased loads in the lower limb, whereas neuromuscular training
protocols seem to have a protective effect on the onset and pro-
gression of OA11,12. Intramuscular administration of Botulinum
toxin A (BTX-A) has been used in the past to induce controlled and
reversible muscle weakness and destabilization of the knee13, and
has caused weakness and signiﬁcant cartilage degradation and
promoted OA8,14. It is generally believed that abnormal mechanicaltd. All rights reserved.
C. Egloff et al. / Osteoarthritis and Cartilage 22 (2014) 1886e1893 1887forces are almost always present in OA, but the question remains if
they act as independent risk factors.
Non-mechanical risk factors are more difﬁcult to deﬁne but
include genetics, obesity, age, sex and inﬂammation. Especially
Inﬂammation and subsequent synovitis have become an inten-
sively studied area in the pathogenesis of OA. Although OA is
deﬁned usually as a non-inﬂammatory disease, there is evidence
that inﬂammatory reactions mediated by the release of pro-
inﬂammatory cytokines result in cartilage degradation, impaired
tissue repair, and act as a trigger for symptomatic OA15e18.
Recently, Erhart-Hledik and colleagues linked mechanical
stimuli and changes in serum cartilage oligomeric matrix protein
(COMP) to cartilage thinning within 5 years indicating that proin-
ﬂammatory cytokines contribute to levels of soluble COMP that
may be released through a trigger event, and subsequently have a
detectable impact on the long term progression of OA19. However,
to date there is no clear evidence if joint inﬂammation represents a
primary cause for the onset of OA, or if inﬂammation is merely a
secondary synovitis resulting from mechanical alterations that is
associated, but not the direct cause of OA.
Carrageenan (a marine polysaccharide) has been used as an in-
ﬂammatorystimulus in anumberof experimentalmodels (e.g.,mice,
rats, rabbits) for half a century. In rabbits, injection of carrageenan
into the knee has been used to induce local and acute inﬂammation,
and the temporal aspects of these inﬂammatory episodes have
been carefully assessed using a variety of techniques20e23.
The aim of this study was to elucidate the effects of mechanical
and inﬂammatory interventions, and the combination of the two,
on the onset and development of OA in the rabbit knee in vivo.
Mechanical interventions included selective and general quadri-
ceps muscle weakness, and inﬂammation was introduced using
intra-articular injections of carrageenan. We hypothesized that
muscle weakness and inﬂammation were independent risk factors
for the development of OA, and that a combination of the two
factors would accelerate osteoarthritic changes in the knee.
Methods
Experimental design
Thirty 1-year-old skeletally mature female New Zealand White
rabbits (weight: average 5.7 kg, range 4.8e6.6 kg; Riemen's Fur-
riers, St. Agatha, Ontario, Canada) were used in accordance with an
experimental protocol approved by the University of Calgary Ani-
mal Care Committee. Animals were housed in pairs in ﬂoor pens to
permit normal activity. Rabbits received a standard diet and water
ad libitum. Animals were divided into four experimental groups,
and one hind limb was randomly assigned for intervention
(experimental hind limb) while the other hind limb served as a
contralateral non-intervened control (control hind limb). For all
interventions, rabbits were anesthetized using a 3.5% isoﬂurane
(Benson Medical) to oxygen mixture.
Group 1: Animals (n ¼ 6) underwent surgical transection of the
nerve branch arising from the common femoral nerve leading to
the vastus lateralis (VL)muscle, thereby preventing activation of VL.
The VL was chosen for nerve transection because it is the biggest
contributor to the extensor force in rabbits and has a laterally ori-
ented ﬁber insertion into the patella, and therefore, when trans-
ected it was thought to result in considerable weakness of the knee
extensor group24, and imbalance in the knee, speciﬁcally the
patellar tracking in the femoral groove.
Group 2: Animals (n ¼ 8) received an injection of BTX-A
(BOTOX, Allergan Inc., Toronto, Ontario, Canada) into the experi-
mental hind limb. Injections of 3.5 U/kg of BTX-A were given once
each month (day 0, 30, 60). Each injection of 3.5 U/kg was dividedequally among three lines of the thigh e medial, central, and
lateral e corresponding to the vastus medialis, rectus femoris, and
VL muscle. The contralateral side received the same amount of
sterile saline.
Group 3: Animals (n ¼ 8) received an intra-articular injection of
commercially available sterile Carrageenan (Sigma Chemical Co; St.
Louis, MO) into the experimental knee joint using 0.5 ml of a 2%
solution21 on day 0 and day 30. This regime was chosen to make
sure that the inﬂammatory reaction induced by the carrageenan
had been resolved by the end of the study. The contralateral side
received 0.5 ml of sterile saline.
Group 4: Animals (n ¼ 8) received a combination of intra-
muscular BTX-A injection monthly and intra-articular injection of
Carrageenan on days 0 and 30 of the experimental period. The
contralateral side received an intra-articular and intra-muscular
injection of sterile saline.
At the end of the experimental period (day 90), rabbits were
sacriﬁced by an intravenous injection of Euthanyl (Bimeda-MTC).
Muscle mass assessment
The heads of the quadriceps muscle group (rectus femoris,
vastus medialis, VL, and vastus intermedius muscle) were isolated
and dissected individually and their wet mass was measured using
a commercial balance with a measuring accuracy of 0.001 g (Met-
tler-Toledo, Switzerland).
Joint width assessment
On the day of sacriﬁce, the width of the experimental and
contralateral knee was measured in all animals using a commer-
cially available digital caliper. Prior to the measurement, hind limbs
were shaved, the joint space between femur and tibia was identi-
ﬁed and the largest medial-lateral diameter was marked. Mea-
surements were repeated three times and the average value was
recorded.
Cartilage histology
The femoral condyle, tibial plateau, and patella were harvested,
photographed with a high resolution digital camera and ﬁxed in a
10% neutral buffered formalin solution for 10 days (Fisher Scientiﬁc,
Wohlen, Switzerland) and then decalciﬁed with Cal-Ex II decal-
cifying solution (10% formic acid solution in 4% formaldehyde,
Fisher Scientiﬁc) and kept at room temperature. The solution was
changed daily. After 2 weeks, joints were opened and returned to a
fresh decalcifying solution for an additional 2e3 weeks. Decalciﬁ-
cationwas ﬁnished when joints could be cut smoothly and without
any grittiness. The joints were then washed thoroughly in running
tap water for 2 h. After decalciﬁcation, the femur was cut into three
pieces (femoral groove, medial and lateral femoral condyle) and the
tibia into two pieces (medial and lateral plateau). Samples were
then processed in an automatic parafﬁn processor (Leica TP 1020
Leica Microsystems, Heerbrugg, Switzerland) where they were
dehydrated in a graded series of alcohols ranging between 80% and
100%, cleared in xylene and inﬁltrated in a mixed Paraplast-plus/
extra wax (Fisher Scientiﬁc). The individual bones of the knee
(tibia, femur, femoral groove, and patella) were then embedded in
parafﬁn molds and stored at room temperature until they were
sectioned. Serial sections of the knee articular cartilage were cut at
12e14 mm thickness using a Leica RM 2165 microtome. Every ﬁfth
section was collected, adhered to Superfrost Plus slides (Fisher
Scientiﬁc) and allowed to dry at 40C for 7 days. All slides were then
stained with hematoxylin, Safranin-O, and fast green (Fisher Sci-
entiﬁc). Sections were then dehydrated in ethanol, cleared in
Fig. 1. Mean (95% CI) of total wet muscle mass (VL, Vastus medialis, Rectus femoris and
Vastus intermedius) for the experimental and control limbs for each intervention
group after 12 weeks. Bars marked with * show signiﬁcant differences in the total
muscle mass between experimental and control limb.
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(Fisher Scientiﬁc) before they were allowed to dry at room tem-
perature for several days.
Sections were viewed on a light microscope (Axiostar plus, Carl
Zeiss, Jena, Germany) by two examiners who were blinded to the
study design. Examinations were made with a 25 objective for
cartilage scoring and a 200 objective to conﬁrm cellular changes.
Two independent graders assessed all sections in a blinded manner
using the OARSI histology scoring system25.
A piece of synovium from the infrapatellar fat pad of all 30 rabbit
knees (experimental and contralateral side) was also embedded in
parafﬁn and sectioned. These sections were stained with Hema-
toxylin & Eosin and cut into 8 mm sections for assessment by image
analysis using the OARSI scoring system25.
Statistical analysis
For analysis of the histological data (OARSI), a non-parametric
Wilcoxon's signed rank test was used to compare differences be-
tween experimental and contralateral control limbs. Differences
between groups were analyzed using a KruskaleWallis followed by
a ManneWhitney U test. SPSS software (version 21.0, SPSS Science
Inc., Chicago, Ill, USA) was used for all analysis. Statistical signiﬁ-
cance was set at P < 0.05. Two independent observers scored all
histological data separately. For inter-examiner reliability testing,




Throughout the course of the study, there were no surgical
complications, infections and no animals died. Two animals in the
Carrageenan/BTX-A group lost temporarily about 20% of their
bodyweight, probably due to the combined systemic effect of BTX-A
and Carrageenan (20.4%, 21.6%, respectively). After changingTable I
Joint diameter and total muscle mass for each intervention group after 12 weeks. Values
Signiﬁcant effect of VL transection, Botox, Carrageenan and Botox plus Carrageenan wer
correction was used to determine differences within groups
Location and
measurement
VL transsection (n ¼ 6) BTX-A (n ¼ 8)
Experimental Control Experimental Control
Joint diameter
(mm)
20.7 (19.8, 21.5) 21.3 (20.8, 21.7) 21.1 (20.2, 22) 21.1 (20, 22
Total muscle
mass (g)
33.0 (26.4, 37.3) 38.9 (36.4, 41.3) 20.0 (16.1, 23.9) 38.3 (35.3,their diet to a high fat diet, both animals recovered quickly and
regained their bodyweight at the time of sacriﬁce (6.3%, 5.6%,
respectively).
All analyses were performed by two independent raters. Inter-
observer reliability was assessed using the ICC. Cronbach's alpha
resulted in 0.85, which was considered as good to very good
reliability.
Quadriceps muscle mass
Surgical transection of the femoral branch leading to the VL
resulted in a signiﬁcant loss in wet muscle mass of the VL muscle
compared to the contralateral side (13.1 g vs 21.8 g, respectively;
P¼ 0.002). Interestingly, total muscle mass of the quadriceps group
was not different between experimental and contralateral hind
limb, because vastus medialis, intermedius and rectus femoris had
increased masses on the experimental side (38.3 g vs 33.0 g,
respectively; P ¼ 0.06), presumably in response to the loss of force
in the VL following denervation.
The isolated administration of BTX-A led to a signiﬁcant loss in
total mass of the quadriceps muscles, as well as all individual heads
of the quadriceps group (48%, P < 0.001). A similar loss in muscle
mass was also found in the combined carrageenan/BTX-A group
(47%, P < 0.001).
There were no changes in total quadriceps muscle mass in the
carrageenan group 3 animals (2%, P ¼ 0.6). Figure 1 summarizes
the changes in quadriceps muscle mass (Fig. 1, Table II).
Joint diameter
Knee joint diameter of the experimental limb was signiﬁcantly
increased compared to contralateral control knees in the carra-
geenan, group 3, animals (means 22.9 mm vs 21.1 mm, resp.;
P ¼ 0.002) and the carrageenan/BTX-A, group 4, animals (means
21.8 mm vs 20.8 mm, resp.; P ¼ 0.01). Joint diameters in the VL
denervation, group 1, (means 20.7 mm vs 21.2 mm, resp. P ¼ 0.17)
and BTX-A injected, group 2, animals, were not different (means
21.1 mm vs 21.1 mm, resp. P ¼ 0.96) (Fig. 2, Table I).
Cartilage histology
Microscopic analysis showed gross visible changes in the tibio-
femoral and the patello-femoral articulations (Fig. 6). Histologic
assessment of the different regions of the knee joint demonstrated
characteristic side-to-side changes in each of the groups. Scores are
shown in Table I as means and corresponding 95% Conﬁdence In-
terval (CI).
VL transection (group 1 animals)
The femoral groove and the backside of the patella showed
signiﬁcantly higher OARSI scores than their contralateral counter-
part (patella: 9.5 vs 6.0, P ¼ 0.03; groove: 8.7 vs 5.8, P ¼ 0.03). The
tibial surface and the femoral condyles showed slightly higherpresented are the mean with 95% Conﬁdence Interval (CI, lower and upper bound).
e determined using a repeated-measures analysis of variance (ANOVA). Bonferroni
Carrageenan (n ¼ 8) BTX-A* carrageenan (n ¼ 8)
Experimental Control Experimental Control
.1) 22.9 (22.1,23.7) 21.1 (20.5, 21.8) 21.8 (21.3,22.3) 20.8 (20.2, 21.3)
41.2) 44.3 (40.4, 48.1) 45.1 (40.8, 49.4) 21.4 (18.6, 24.2) 40.1 (38.2, 42)
Table II
Mean OARSI Scores for the experimental limbs and for all four intervention groups at 12 weeks (95% CI, lower and upper bound). Signiﬁcant differences between experimental
and contralateral side were determined using the Wilcoxon signed rank test. Numbers marked with * show signiﬁcant increases in OA in the experimental knee across the
intervention groups using a KruskaleWallis test, followed by a ManneWhitney U test. Bonferroni correction was used for posthoc analysis. NS ¼ not signiﬁcant
Intervention Patella Groove Femur Tibia Synovium
OARSI score
(CI 95%, LI, UI)
P-value OARSI score
(CI 95%, LI, UI)
P-value OARSI score
(CI 95%, LI, UI)
P-value OARSI score
(CI 95%, LI, UI)
P-value OARSI score
(CI 95%, LI, UI)
P-value
VL trans 9.5 (8, 10.9) 0.03* 8.7 (8.1, 9.8) 0.03 8.3 (6.1, 10.8) 0.24 (ns) 6.2 (5.1, 7.1) 0.23 (ns) 2.8 (2.4, 3.3) 0.29 (ns)
Botox 10.6 (9.2, 11.7) 0.04* 11.4 (10.8, 12.1) 0.03 10.3 (8.5, 11.9) 0.012* 9.3 (6.9, 11.6) 0.011 3.8 (3.4, 4.4) 0.13
Carrageenan 8.6 (7.4, 9.7) 0.13 (ns) 8.6 (7.7, 9.6) 0.28 (ns) 8.4 (6.9,9.9) 0.07 (ns) 7.8 (6, 9.5) 0.48 (ns) 10.6 (7.1, 13.2) 0.012
B&C 11.0 (10.1, 12) 0.017* 11.2 (12, 10.3) 0.012 15.4 (13.5, 17) 0.011* 10.9 (7.9, 13.8) 0.012 8.9 (8.3, 9.5) 0.012
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niﬁcance (tibia: 8.3 vs 6.9; femur 8.8 vs 6.1, respectively). Cartilage
damage occurred primarily on the medial side of the patella and
femoral groove. Cartilage damage in the tibio-femoral joints
occurred exclusively in the medial compartment.BTX-A (group 2 animals)
Administration of BTX-A resulted in severe cartilage damage in
all four compartments of the knee with signiﬁcant increases in
OARSI scores: patella: 10.6 vs 6.9, P ¼ 0.04; groove: 12.4 vs 7.6,
P ¼ 0.03; tibia: 8.3 vs 4.0, P ¼ 0.01; femur: 10.0 vs 5.3, P ¼ 0.012.
Cartilage damage in the tibio-femoral joints was located in the
medial compartment, whereas cartilage damage occurred primar-
ily on the lateral side of the patello-femoral joint.Carrageenan (group 3 animals)
Intraarticular injection of carrageenan did not result in consis-
tent differences between experimental and control knees. Experi-
mental knees showed a trend towardsmarginally higher scores, but
did not reach statistical signiﬁcance: patella: 8.6 vs 7.6, P ¼ 0.13;
groove: 8.6 vs 6.8, P ¼ 0.28; tibia: 8.5 vs 7.0, P ¼ 0.46; femur: 9.0 vs
7.1, P ¼ 0.07. Cartilage damage in the patello-femoral joint occurred
about equally on the medial and lateral side. Cartilage damage in
the tibio-femoral joint occurred predominantly on the medial side.Carrageenan/BTX-A (group 4 animals)
The combination of BTX-A induced muscle weakness and
carrageenan induced joint inﬂammation resulted in severe carti-
lage damage in the patella (11.0 vs 6.1; P¼ 0.017), the groove (8.6 vs
6.8; P ¼ 0.012), the tibia (11.3 vs 5.8; P ¼ 0.012) and the femur (14.4
vs 6.0; P ¼ 0.011). Cartilage damage occurred primarily on the
medial side of the tibio-femoral joint and the lateral side of the
patello-femoral joint.Fig. 2. Mean (95% CI) of joint diameter (mm) between experimental and control limbs
across intervention groups. Bars marked with * show signiﬁcant differences in the joint
diameter between experimental and control limbs.Cartilage subanalysis
The overall analysis between interventions showed a trend
towards the lowest OARSI scores in the VL denervation group 1
animals and the highest scores for the carrageenan/BTX-A group 4
animals (P ¼ 0.065). Analysis across knee joint compartments
(patella, groove, tibia, femur) revealed that the Carrageenan group
3 animals showed signiﬁcantly lower OARSI scores in the femoral
groove (P ¼ 0.039), the femur (P ¼ 0.027) and the tibia (P ¼ 0.042)
than the carrageenan/BTX-A group. The VL denervation group 1
rabbits had lower scores in the femoral groove (P ¼ 0.037), tibia
(P¼ 0.05) and femur (P < 0.01) compared to the carrageenan/BTX-A
group animals (Table II).
Further analysis of the OARSI score revealed speciﬁc differences
between intervention groups: For the patella, the carrageenan/BTX-
A group 2 animals had signiﬁcantly more cellular cluster forma-
tions than the VL denervation group 1 animals (P ¼ 0.027) and the
carrageenan group 3 animals (P¼ 0.01). For the femoral groove, the
carrageenan/BTX-A group 4 animals had more cellular clustering
than the Carrageenan group 3 animals, and signiﬁcant more loss of
staining than the VL denervation group 1 animals. For the femoral
condyles and the tibial plateau, the Botox and Carrageenan (B&C)
group 4 animals had signiﬁcantly more structural deﬁcits than the
VL denervation group 1 animals (P¼ 0.017, P¼ 0.042; respectively).
Synovial analysis
The histological analysis according to the OARSI score revealed
signiﬁcant higher scores in the Carrageenan (10.6 vs 3.9; P ¼ 0.01)
and carrageenan/BTX-A groups (8.9 vs 2.9; P¼ 0.01) (Fig. 4, Table II).
The synovium of the VL transection (2.8 vs 2; P ¼ 0.29) and the
isolated Botox group (3.8 vs 2.8; P ¼ 0.13) were unaffected (Fig. 5).
The synovial subanalysis across intervention groups showed sig-
niﬁcant higher scores for proliferation and hypertrophy (P < 0.001),
lymphoplasmatic inﬁltrate (P < 0.001) and angiogenesis (P¼ 0.006)
in both groups with injected carrageenan (group 2, 4) compared to
groups one and three.
Discussion
Over the past decade, it has become accepted that abnormal
joint mechanics are one of the greatest risk factors for the onset and
increased rate of OA severity26. Also, it has been found that in the
advanced stages of OA, an inﬂammatory reaction is almost always
present. In the present study, we aimed to determine the effects of
isolated muscle weakness and isolated joint inﬂammation, as well
as the superposition of these two factors, on the onset and severity
of OA. Our results showed that severe muscle weakness, produced
by intramuscular administration of BTX-A, resulted in signiﬁcant
cartilage degradation in all compartments of the knee when
compared to the contralateral, non-injected side. Also, a select
muscle imbalance caused by a denervation of the VL muscle, was
Fig. 3. Mean (95% CI) OARSI scores for the experimental and control limbs for each intervention group after 12 weeks according to the anatomical region. Bars marked with * show
signiﬁcant differences in the OARSI score between experimental and control limb.
C. Egloff et al. / Osteoarthritis and Cartilage 22 (2014) 1886e18931890associated with a signiﬁcant loss of cartilage in the patello-femoral
joint, indicating a disturbance of normal patella-femoral joint
mechanics.
In contrast, selective administration of a transient inﬂammatory
stimulus through intra-articular injection of carrageenan did not
result in a signiﬁcant increase in the progression of OA over
3 months. However, it did lead to a severe inﬂammatory reaction in
synovial tissue as seen in Figs. 4 and 5.
Our hypothesis that an inﬂammatory stimulus in an otherwise
healthy knee joint acts as an independent risk factor for OA pro-
gression was not supported by our results. However, when muscle
weakness was combined with a local inﬂammation there was a
trend towards an increased rate of cartilage damage compared to
muscle weakness alone (Fig. 3). Therefore, either the carrageenan-
induced inﬂammatory reaction was not sufﬁciently strong toFig. 4. Mean (95% CI) of OARSI scores of the synovium for the experimental and
control limbs for each intervention group after 12 weeks. Bars marked with * show
signiﬁcant differences in the OARSI score between experimental and control limbs.enhance the impact of the muscle weakness at the doses used, or
perhaps being an acute stimulus, it did not lead to a chronic
inﬂammation which may be required for OA progression.
The results of this study suggest that alterations in joint me-
chanics through muscle weakness are an important and powerful
risk factor for OA, and an accompanying joint inﬂammation might
be a contributing factor in the pathogenesis of OA.
OA is often described as a multi-factorial disease, and thus, in
the human disease, it is often hard to study and virtually impossible
to disentangle the various contributing factors. In order to prevent
or stop the progression of OA, it may be useful to evaluate to what
extent different causes or risk factors of OA contribute to the dis-
ease. Major risk factors for knee OA are age, female gender, obesity,
traumatic injuries, pathological biomechanics and chronic exces-
sive overuse26e28. Muscle weakness has been linked to an increased
rate of radiographic joint space narrowing9 and to an acceleration
of OA development in elderly community-dwelling women29.
Moreover, decreased isokinetic quadriceps muscle strength in
women has been found to lead to increased lower limb loading
during walking, and has been associated with both the initiation
and progression of OA11. Furthermore, it has been demonstrated
that muscle weakness can result in OA, and our results agree with
those described in the literature6,8,14. In BTX-A group animals
(group 2), we found signiﬁcant cartilage degradation not only in the
patello-femoral but also in the tibio-femoral joints suggesting that
the severe muscle weakness caused by the toxin acted as a major
contributor to OA progression in the rabbit model. Our results
showed more severe cartilage damage than comparable previous
studies. One reason for these differences may be that this experi-
ment was conducted over a longer period of time, e.g., 3 months
instead of 4 weeks8.
The denervation of the VL resulted in cartilage degradation
concentrated on the medial side of the patello-femoral joint, but
did not produce differences in cartilage damage between
Fig. 5. Microscopic analysis of synovium sample (20 magniﬁcation). A: Synovial probe of group 1 animals (VL transection) with OARSI score 2. B: Synovial example of group 2
(BTX-A injection) showing mild synovial reaction with an OARSI score of 4. C: Example of group 4 (BTX-A/Carrageenan) showing severe synovial inﬂammatory reaction with an
OARSI score of 11. D: Synovial example of group 3 (Carrageenan) with severe inﬂammatory reaction with an OARSI score of 16.
C. Egloff et al. / Osteoarthritis and Cartilage 22 (2014) 1886e1893 1891experimental and control knees in the tibio-femoral joint. This
observation conﬁrmed our hypothesis that an asymmetrical
quadriceps weakness has a greater effect on the mechanics of the
patello-femoral than the tibio-femoral compartments. A limitation
of this study is that we did not measure absolute muscle forces or
patello-femoral kinematics or contact pressure distributions to
substantiate this hypothesis. However, previous studies showed the
effect of selectivemuscle weakness onmuscle strength and patello-
femoral joint kinematics30. Therefore, we assume that the dener-
vation of the VL, and associated loss of force, led to a force overload
on the medial side of the patello-femoral joint, a corresponding
alteration in patello-femoral joint kinematics, and ﬁnally, to the
localized cartilage loss on themedial side of the patella and femoral
groove. This result emphasizes the importance of balanced muscle
strength on knee joint mechanics, especially for the patello-femoral
compartment. Another limitation of this study is that we used the
contralateral joint as the control and did not use a sham control
group. It is possible that the impact of the experimental side could
have inﬂuenced the control side and would have derogated the
results. However, we observed signiﬁcant changes in histology in
the experimental knees of BTX-A group animals compared to the
corresponding contralateral control knee, while the carrageenan
group animals did not show consistent changes between experi-
mental and control knees. The OARSI scores of these joints were
comparable with values from non-experimental control animals
observed in other studies using sham controls, suggesting that our
observations were similar to sham control knees8.
Acute inﬂammatory reactions, with an up-regulation of pro-
inﬂammatory cytokines, are commonly observed after traumaticintra-articular injuries15,31. Recent studies suggest that a stimulus-
response system between mechanical and biochemical factors
could play a role in the incidence and progression of OAwith crucial
long-term effects19. In this study, we did not ﬁnd a signiﬁcant effect
of a transient inﬂammatory stimulus on articular cartilage damage
of the knee. However, we observed an increase in the OARSI his-
tology scorewhen the inﬂammatory reactionwas superposed to the
muscleweakness compared towhenmuscleweaknesswas induced
in isolation. A similar trend of increased cartilage damagedwas seen
when we compared the carrageenan-injected with the corre-
sponding control limbs. One explanation for our ﬁndings could be
that mechanical factors have a much greater effect than transient
inﬂammatory reactions. If this is indeed the case, one might spec-
ulate that inﬂammation plays only a secondary, accompanying role
in the onset and progression of OA, which then raises the question
of the effect of treatments of acute inﬂammation in OA.
In this study, the healthy contralateral kneewas used as a control
for the experimental limb, thereby accounting for inter-animal dif-
ferences in the natural progression of OA with aging. Using this
approach, we found distinct and highly signiﬁcant differences in
OARSI scores between experimental and contralateral control knees
in the BTX-A and the VL group animals, but not the inﬂammation
groupanimals.Another explanation forourﬁndings couldbe that the
inﬂammatory stimulus administered by the intra-articular injection
of carrageenan was too small to result in a relevant inﬂammatory
response. Due to the experimental setup we could not quantify the
inﬂammatory reactions with synovial ﬂuid or blood serum analyses.
However,we observed signiﬁcant soft tissue and joint swellingof the
knee in both carrageenan groups. Also we did ﬁnd a severe synovial
Fig. 6. Microscopic images of three different animals in 5magniﬁcation (A, C, E) and 20magniﬁcation (B, D, F). All histological slides are examples from the femoral condyle. A, B:
contralateral control side from a specimen of the BTX-group showing an OARSI score of 3 (normal). C, D: experimental side from a specimen of the BTX/carrageenan-group showing
an OARSI score of 12 (moderate OA) E, F: experimental side from a specimen of the BTX-group showing an OARSI score of 18 (severe OA).
C. Egloff et al. / Osteoarthritis and Cartilage 22 (2014) 1886e18931892reaction in both groups treated with carrageenan suggesting that a
true inﬂammatory reaction had taken place in those experimental
groups. Furthermore, other studies indicate that a single carrageenan
injection causes a severe but transient inﬂammatory reaction and
tissue response, which returns to baseline after about 28 days20,21.
Thus, injections on days 0 and 30 as done here, would produce an
acute phase of inﬂammation that would most likely be resolved by
the end of the 3 months experimental period. However, we focused
on investigating the progression of OA in the presence of a local in-
ﬂammatory stimulus and/or speciﬁc muscle weakness, rather than
on the acute effects of inﬂammation.
Conclusion
Quadriceps weakness and imbalance over a period of time leads
to the onset and progression of OA in the rabbit knee. A transient
local inﬂammatory stimulus did not promote cartilage degradation,
nor did it signiﬁcantly increase the severity of OA when combined
withmuscle weakness. This result is somewhat surprising and adds
to the literature indicating that acute inﬂammation may not be a
strong independent risk factor for OA in this model system.Author contributions
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